Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine About Us Budget'26 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Shares of Dabur Fall 5 Percent as UBS Downgrades to Neutral on Valuation Concerns

    Shares of Dabur Fall 5% as UBS Downgrades to 'Neutral' on Valuation Concerns


    Finance Outlook India Team | Wednesday, 25 September 2024

    During Wednesday's intraday trade on the BSE, shares of Dabur dropped 5% to Rs 622 following a downgrading from 'Buy' to 'Neutral' by international brokerage UBS. UBS increased Dabur's target price from Rs 650 to Rs 700 in spite of the downgrading.

    The brokerage expressed worries about the stock's high price and possible threats to the expansion of beverage sales. Dabur's sales may potentially be impacted by growing competition from brands of coconut oil and cola beverages.

    UBS is still upbeat about the company's chances for sales growth over the following five years, though. The stock has increased by 12% so far this year, and it has gained 20% over the last six months.

    Compared to the same period last year, Dabur's consolidated net profit increased by 8% to Rs 500.12 crore in Q1 FY25 from Rs 463.88 crore. Consolidated net profit after taxes from ongoing activities increased by 18% to Rs 1,981 from Rs 1,675 crore recorded in the same period last year.

    The reported quarter's operating revenue of Rs 3,349.11 crore represented a 7% increase over the corresponding quarter's revenue of Rs 3,130.47 crore in the preceding fiscal year. The consolidated profit after tax (PAT) increased 43% sequentially from Rs 349.53 crore in Q4FY24. In Q4FY24, revenue increased by 19% on a quarter-over-quarter basis to Rs 2,814.64 crore.

    The stock's relative strength index (RSI) is 53.6 from a technical perspective. An RSI of less than 30 is regarded as oversold, while one above 70 denotes overbought conditions, according to Trendlyne. Furthermore, the MACD is at 7.7, above the signal line but below the center line.

    While the stock is trading below its 5-day, 10-day, 20-day, 30-day, and 50-day SMAs, it is trading above its 100-day, 150-day, and 200-day SMAs.



    Read More:

    ConvoZen Launches End-to-End Conversational AI

    India & France Revise Tax Treaty, Scrap MFN Clause, Ease Dividends

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe WRAPUP’25